- Analysis of Circulating Tumor DNA Kinetics during Stereotactic Ablative Radiation Therapy for Non-Small Cell Lung CancerChen E. L.; Chaudhuri A. A.; Nabet B. Y.; Chabon J. J.; Merriott D. J.; Loo B. W. Jr.; Alizadeh A. A.; Diehn M.60th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), 2018-10-21 To 2018-10-24.
- Analysis of Circulating Tumor DNA (ctDNA) in Triple Negative and HER2 Positive Breast Cancer Patients throughout Neoadjuvant Chemotherapy. A Proof of Concept StudyCiriaco, Nikaoly; Zamora, Esther; Escriva de Romani, Santiago; Somoza, Rosa; Hernandez-Losa, Javier; Ramon Y Cajal, Santiago; Peg, Vicente; Espinosa-Bravo, Martin109th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Los Angeles, CA, 2020-02-29 To 2020-03-05.
- 5P Circulating tumour DNA (ctDNA) dynamics using a standardized multi-gene panel in advanced breast cancer patients (pts) treated with CDK4/6 inhibitors (CDK4/6i)O. Martínez-Sáez; T. Pascual; F. Brasó-Maristany; N. Chic; B. González-Farré; E. Sanfeliu; A. Rodríguez; D. Martínez; P. Galván; A. Rodriguez Hernandez; F. Schettini; B. Conte; M.J. Vidal; B. Adamo; M. Muñoz; R. Moreno; E.M. Ciruelos; I. Faull; A. PratAnnals of Oncology, 2020, 31: s17.
会议论文
Using Circulating Tumor DNA (ctDNA) As Screening and Predictive Marker in Cervical Carcinoma Patients Receiving Radiation Therapy
11阅读
